Mycoplasma pneumoniae (MP) is a common cause of pneumonia that can cause mucocutaneous disease in 25%-30% of patients. 1 In 2015, Canavan introduced MIRM to describe the unique set of mucocutaneous eruptions due to MP. 2 MIRM is an entity distinct from erythema multiforme (EM) and Stevens-Johnson syndrome (SJS) due to its predominance of mucosal involvement and better prognosis than the latter. 2 In recent years, other infectious etiologies such as Chlamydia pneumoniae, influenza B, adenovirus, and group A Streptococcus have been described to produce mucocutaneous eruptions indistinguishable from MIRM. [3][4][5][6][7][8] This has led to the term reactive infectious mucocutaneous eruption (RIME) as a reflection that other infections may stimulate this mucocutaneous eruption. Recurrent episodes are poorly understood. Reports have estimated a recurrence rate ranging from 9% to 38%. 9 In this report, we describe in detail two cases of recurrent RIME with initial episodes suspected to be triggered by MP. Subsequent episodes were caused by other viral infections including SARS-CoV-2 and influenza A.